BACKGROUND: Carotid-femoral pulse wave velocity (cfPWV) is the gold standard for noninvasive arterial stiffness assessment, an independent predictor of cardiovascular disease, and a potential parameter to guide therapy. However, cfPWV is not routinely measured in clinical practice due to the unavailability of a low-cost, operator-friendly, and independent device. The current study validated a novel laser Doppler vibrometry (LDV)-based measurement of cfPWV against the reference technique. METHODS: In 100 (50 men) hypertensive patients, cfPWV was measured using applanation tonometry (Sphygmocor) and the novel LDV device. This device has 2 handpieces with 6 laser beams each that simultaneously measure vibrations from the skin surface at carotid and femoral sites. Pulse wave velocity is calculated using ECG for the identification of cardiac cycles. An ECG-independent method was also devised. Cardiovascular risk score was calculated for patients between 40 and 75 years old using the WHO risk scoring chart. RESULTS: LDV-based cfPWV correlated significantly with tonometry (r=0.86, P <0.0001 ECG-dependent [cfPWV LDV_ECG ] and r=0.80, P <0.001 ECG-independent [cfPWV LDV_w/oECG ] methods). Bland-Altman analysis showed nonsignificant bias (0.65 m/s) and acceptable SD (1.27 m/s) between methods. Intraobserver coefficient of variance for LDV was 4.7% (95% CI, 3.0%–5.5%), and interobserver coefficient of variance was 5.87%. CfPWV correlated significantly with CVD risk (r=0.64, P <0.001; r=0.41, P =0.003; and r=0.37, P =0.006 for tonometry, LDV-with, and LDV-without ECG, respectively). CONCLUSIONS: The study demonstrates clinical validity of the LDV device. The LDV provides a simple, noninvasive, operator-independent method to measure cfPWV for assessing arterial stiffness, comparable to the standard existing techniques. REGISTRATION: URL: https://clinicaltrials.gov/study/NCT03446430 ; Unique identifier: NCT03446430.
19 January 2022 in Ultrasound in Medicine & Biology
Fluorescence labeling is commonly used to enhance microscopy image contrast and facilitate automated Giant Unilamellar Vesicles (GUVs) quantification. Nonetheless, fluorescent probes may introduce unaccounted variations compared to the intended pristine formulation. Alternatively, phase-contrast microscopy enables label-free GUVs observation, but the lack of reliable automated detection methods limits high throughput analyses. To address this gap, we developed a framework based on YOLOv11 model, a state-of-art lightweight convolutional neural network for object detection. Trained on 4666 manually annotated GUVs from 164 phase-contrast microscope images, the model enables robust detection under low contrast-to-noise ratio and heterogeneous illumination. The trained model is implemented in a stand-alone desktop application supporting multiple analysis in a single run, pixel-to-micrometer calibration, and automated size distribution analysis. Retraining scripts compatible with standard hardware are also provided to enhance adaptability. VesiScope achieves high detection accuracy and competitive cross-microscope generalization enabling fast and reliable analysis of unaltered GUVs, supporting experimental reproducibility.